Nanjing Changao Pharmaceutical

Nanjing Changao Pharmaceutical, a subsidiary of Shionogi China, is a comprehensive pharmaceutical company based in Nanjing, China, specializing in the research, development, and manufacturing of a wide range of therapeutic products. Founded in 1997 and later integrated into the Shionogi Group, the company operates modern GMP-certified facilities producing various dosage forms, including tablets, capsules, and freeze-dried powder injections. Its product portfolio spans multiple therapeutic areas such as cardiovascular, digestive, and infectious diseases, with notable brands like Aoding (pitavastatin) and Aobo Ping (rabeprazole). In addition to its commercial operations, Nanjing Changao maintains an active R&D pipeline focusing on innovative treatments for conditions like chronic hepatitis B and pulmonary tuberculosis.